By eigindia Multinationals should stop treating Indians as guinea pigs, the FDA told the Bombay HC on Friday, while opposing Johnson & Johnson’s application for a stay on an order directing the recall of faulty hip implants. The FDA emphasized that the health and safety of Indian citizens should not be compromised, and it is essential to prioritize their well-being over corporate interests. This statement came amid growing concerns over the quality and safety of medical devices and products marketed in India. The FDA’s stance underscores the need for stricter regulations and accountability in the pharmaceutical and medical device industries to protect public health.
An ENT blog by Dr. B. P. Tyagi